KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,048 | +33.0% | 175,525 | +7.9% | 0.00% | +100.0% |
Q2 2023 | $2,291 | +31.3% | 162,658 | +0.3% | 0.00% | 0.0% |
Q1 2023 | $1,745 | +94.1% | 162,179 | +170.3% | 0.00% | – |
Q4 2022 | $899 | -99.7% | 60,007 | +168.6% | 0.00% | – |
Q3 2022 | $287,000 | +81.6% | 22,341 | +36.5% | 0.00% | – |
Q2 2022 | $158,000 | -19.0% | 16,372 | -16.7% | 0.00% | – |
Q1 2022 | $195,000 | -85.1% | 19,661 | -82.3% | 0.00% | – |
Q4 2021 | $1,306,000 | +49.8% | 111,068 | +45.1% | 0.00% | – |
Q3 2021 | $872,000 | +217.1% | 76,560 | +286.1% | 0.00% | – |
Q2 2021 | $275,000 | -94.2% | 19,829 | -92.2% | 0.00% | -100.0% |
Q1 2021 | $4,729,000 | -60.7% | 255,536 | -62.5% | 0.00% | -50.0% |
Q4 2020 | $12,031,000 | +172.4% | 680,900 | +136.1% | 0.01% | +100.0% |
Q3 2020 | $4,417,000 | +944.2% | 288,388 | +1638.1% | 0.00% | – |
Q2 2020 | $423,000 | +336.1% | 16,592 | +166.5% | 0.00% | – |
Q1 2020 | $97,000 | -52.0% | 6,225 | -66.0% | 0.00% | – |
Q4 2019 | $202,000 | +106.1% | 18,283 | +60.1% | 0.00% | – |
Q3 2019 | $98,000 | -35.1% | 11,419 | +2.4% | 0.00% | – |
Q2 2019 | $151,000 | +88.8% | 11,155 | +155.6% | 0.00% | – |
Q1 2019 | $80,000 | -7.0% | 4,365 | +42.9% | 0.00% | – |
Q4 2018 | $86,000 | +38.7% | 3,054 | +25.7% | 0.00% | – |
Q3 2018 | $62,000 | – | 2,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |